TECH | tickerfilter.com

Fundamental analysis

40%

Profitability 24%

Dept financing 40%

Liquidity 37%

Performance 56%

Company vs Stock growth

+ Add row to compare

Performance

5 Days

-1.04%

1 Month

-14.29%

3 Months

-30.04%

6 Months

-28.97%

1 Year

-22.11%

2 Year

-36.58%

Key data

Stock price

$50.25

P/E Ratio

72.37

DAY RANGE

$49.74 - $51.53

EPS

$0.43

52 WEEK RANGE

$46.01 - $85.57

52 WEEK CHANGE

-$20.50

MARKET CAP

11.445 B

YIELD

0.44%

SHARES OUTSTANDING

158.600 M

DIVIDEND

$0.08

EX-DIVIDEND DATE

02-14-2025

NEXT EARNINGS DATE

05-07-2025

BETA

1.02

PUBLIC FLOAT

AVERAGE 10 VOLUME

$1,978,552

AVERAGE 30 VOLUME

$2,312,948

Company detail

CEO: Charles R. Kummeth
Region: US
Website: bio-techne.com
Employees: 3,000
IPO year: 1992

Issue type: Common Stock
Market: XNAS
Industry: Pharmaceutical Products/Biological Products, Except Diagnostic Substances
Sector: Manufacturing

Bio-Techne Corporation develops, manufactures, and sells life science reagents, instruments, and services. Protein Sciences segment provides biological reagents used in various aspects of life science research, diagnostics, and cell and gene therapy. Diagnostics and Genomics segment provides diagnostic products, including controls, calibrators, and diagnostic assays for regulated diagnostics market.

TECH - BIO-TECHNE Corp